These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 27125052)
21. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS. Pritchett J; Mixon W; O'Connell K Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054 [TBL] [Abstract][Full Text] [Related]
22. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment. Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508 [TBL] [Abstract][Full Text] [Related]
23. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265 [TBL] [Abstract][Full Text] [Related]
24. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program. Griffiths T; Connors A Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174 [TBL] [Abstract][Full Text] [Related]
25. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies. Yoch D Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203 [TBL] [Abstract][Full Text] [Related]
26. Basics of sterile compounding: bubble point testing. Thoma L Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342 [TBL] [Abstract][Full Text] [Related]
27. Protecting consumers from counterfeit drugs. FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
28. Establishment of galenic laboratories in developing countries to produce high quality medicines: results of Aid Progress Pharmacist Agreement (A.P.P.A.®) Project. Baratta F; Germano A; Di Lascio G; Petieau R; Brusa P Croat Med J; 2014 Dec; 55(6):662-8. PubMed ID: 25559838 [No Abstract] [Full Text] [Related]
29. GMPs vs GCPs: manufacturing and compounding definitions. Allen LV Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778 [No Abstract] [Full Text] [Related]
30. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding. Ligugnana R Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779 [TBL] [Abstract][Full Text] [Related]
31. One-way distribution system for water for injection: process management, microbiological quality control, and meeting regulatory requirements. Jahnke M PDA J Pharm Sci Technol; 2001; 55(1):3-9. PubMed ID: 11212418 [TBL] [Abstract][Full Text] [Related]
32. Quality planning, part 1: a holistic and practical approach. Odegard RD Int J Pharm Compd; 2013; 17(5):393-9. PubMed ID: 24459786 [TBL] [Abstract][Full Text] [Related]
33. Traditional vs. nontraditional pharmacy. Allen LV Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152 [No Abstract] [Full Text] [Related]
34. Compounding our problems--again. Trissel LA Am J Health Syst Pharm; 2003 Mar; 60(5):432. PubMed ID: 12635448 [No Abstract] [Full Text] [Related]
35. Survey of sterile product compounding practices in Canadian hospital pharmacies. Fitch DP; Hall KW Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343 [TBL] [Abstract][Full Text] [Related]
36. Quality Assurance and Quality Control, Part 2. Akers MJ Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362 [TBL] [Abstract][Full Text] [Related]
37. 2013 State Compounding Legislation Tracker. Miller DG Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782 [No Abstract] [Full Text] [Related]